Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin and 5-fluorouracil in advanced colorectal cancer
NCT01941953Phase 2Completed
- Sponsor
- Instituto do Câncer do Estado de São Paulo
- Start
- Nov 2012
- Primary completion
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of liquid metformin (Aspargo Labs) in metastatic colorectal cancer (mCRC), sponsored by Instituto do Câncer do Estado de São Paulo. Primary endpoint: Disease Control Rate at 8 weeks. Started Nov 2012; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT01941953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01941953.